{"id":8174,"date":"2025-04-04T03:30:11","date_gmt":"2025-04-03T19:30:11","guid":{"rendered":"https:\/\/regask.com\/?p=8174"},"modified":"2025-04-09T14:29:54","modified_gmt":"2025-04-09T06:29:54","slug":"%e5%a2%a8%e8%a5%bf%e5%93%a5gmp%e5%90%88%e8%a7%84%e6%80%a72025","status":"publish","type":"post","link":"https:\/\/regask.com\/zh\/mexico-gmp-compliance-2025\/","title":{"rendered":"COFEPRIS\uff08\u58a8\u897f\u54e5\uff09\u53d1\u5e03GMP\u6587\u4ef6\u6307\u5357\u2026\u2026"},"content":{"rendered":"<p data-pm-slice=\"1 3 []\">2025\u5e743\u670820\u65e5\uff0c\u58a8\u897f\u54e5\u8054\u90a6\u5065\u5eb7\u98ce\u9669\u4fdd\u62a4\u59d4\u5458\u4f1a\uff08COFEPRIS\uff09\u5728\u5b98\u65b9\u516c\u62a5\uff08DOF\uff09\u4e0a\u53d1\u5e03\u4e86\u300a\u5173\u4e8e\u53d1\u5e03\u6d3b\u6027\u6210\u5206\u3001\u836f\u54c1\u548c\u533b\u7597\u5668\u68b0\u826f\u597d\u751f\u4ea7\u89c4\u8303\uff08GMP\uff09\u4fdd\u8bc1\u6587\u4ef6\u63d0\u4ea4\u6307\u5357\u7684\u534f\u8bae\u300b\u3002\u8be5\u6307\u5357\u9002\u7528\u4e8e\u65b0\u7684\u5065\u5eb7\u6ce8\u518c\u7533\u8bf7\u53ca\u5176\u5ef6\u671f\u548c\u4fee\u6539\u3002\u65b0\u5236\u5b9a\u7684\u6cd5\u89c4\u660e\u786e\u4e86\u63d0\u4ea4GMP\u6587\u4ef6\u7684\u8981\u6c42\u548c\u6807\u51c6\uff0c\u65e8\u5728\u7b80\u5316\u7b26\u5408\u56fd\u9645\u6807\u51c6\u7684\u6d41\u7a0b\uff0c\u5e76\u52a0\u5f3a\u4e0e\u516c\u8ba4\u76d1\u7ba1\u673a\u6784\u7684\u5408\u4f5c\u3002<\/p>\n<h4><strong>\u5173\u952e\u4eae\u70b9<\/strong><\/h4>\n<ul data-spread=\"false\">\n<li>\u300a\u6307\u5357\u300b\u89c4\u5b9a\u4e86\u836f\u54c1\u6210\u5206\u3001\u836f\u54c1\u3001\u533b\u7597\u5668\u68b0\u5728\u536b\u751f\u6ce8\u518c\u7533\u8bf7\u3001\u7eed\u5c55\u3001\u53d8\u66f4\u7b49\u8fc7\u7a0b\u4e2d\u9700\u8981\u63d0\u4ea4\u7684\u5fc5\u8981\u6587\u4ef6\uff0c\u5305\u62ec\u300a\u826f\u597d\u751f\u4ea7\u89c4\u8303\u8bc1\u4e66\u300b\u6216\u540c\u7b49\u6587\u4ef6\u3002<\/li>\n<li>\u6211\u4eec\u5f3a\u8c03\u9075\u5b88\u56fd\u9645 GMP \u6807\u51c6\uff0c\u4ee5\u786e\u4fdd\u6574\u4e2a\u5236\u9020\u8fc7\u7a0b\u4e2d\u4ea7\u54c1\u7684\u5b89\u5168\u6027\u3001\u6709\u6548\u6027\u548c\u4e00\u81f4\u6027\u3002<\/li>\n<li>\u53d7\u5f71\u54cd\u7684\u4ea7\u54c1\u7c7b\u522b\u5305\u62ec\uff1a\n<ul data-spread=\"false\">\n<li>\u6d3b\u6027\u836f\u7269\u6210\u5206 (API)<\/li>\n<li>\u975e\u5904\u65b9\u836f<\/li>\n<li>\u5904\u65b9\u836f<\/li>\n<li>\u5404\u79cd\u533b\u7597\u8bbe\u5907\uff0c\u5305\u62ec\u8bca\u65ad\u548c\u6cbb\u7597\u8bbe\u5907<\/li>\n<\/ul>\n<\/li>\n<li>\u8be5\u6cd5\u89c4\u4fc3\u8fdb\u4e0e\u5168\u7403\u516c\u8ba4\u7684\u76d1\u7ba1\u673a\u6784\u7684\u534f\u8c03\uff0c\u53ef\u80fd\u6709\u52a9\u4e8e\u5408\u89c4\u4ea7\u54c1\u66f4\u5bb9\u6613\u8fdb\u5165\u56fd\u9645\u5e02\u573a\u3002<\/li>\n<li>\u9f13\u52b1\u5236\u9020\u5546\u4e25\u683c\u9075\u5b88\u8fd9\u4e9b\u51c6\u5219\uff0c\u4ee5\u4fdd\u6301\u6ce8\u518c\u72b6\u6001\u5e76\u786e\u4fdd\u65b0\u7684\u6216\u4fee\u6539\u7684\u5065\u5eb7\u6ce8\u518c\u7684\u5ba1\u6279\u6d41\u7a0b\u66f4\u52a0\u987a\u5229\u3002<\/li>\n<\/ul>\n<h4><strong>\u4e0b\u4e00\u6b65<\/strong><\/h4>\n<ul data-spread=\"false\">\n<li>\u5236\u9020\u5546\u5e94\u8bc4\u4f30\u5e76\u66f4\u65b0\u5176 GMP \u6587\u6863\u4ee5\u7b26\u5408\u65b0\u7684 COFEPRIS \u6307\u5357\u3002<\/li>\n<li>\u516c\u53f8\u5e94\u786e\u4fdd\u5176\u751f\u4ea7\u6d41\u7a0b\u548c\u8d28\u91cf\u63a7\u5236\u7cfb\u7edf\u7b26\u5408\u4fee\u8ba2\u540e\u7684\u76d1\u7ba1\u8981\u6c42\u3002<\/li>\n<li>\u5bc6\u5207\u76d1\u6d4b\u76d1\u7ba1\u66f4\u65b0\u5e76\u79ef\u6781\u4e0e COFEPRIS \u5408\u4f5c\u5bf9\u4e8e\u4fdd\u6301\u5408\u89c4\u6027\u548c\u7b80\u5316\u5ba1\u6279\u6d41\u7a0b\u81f3\u5173\u91cd\u8981\u3002<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>2025\u5e743\u670820\u65e5\uff0c\u58a8\u897f\u54e5\u8054\u90a6\u536b\u751f\u98ce\u9669\u9632\u62a4\u59d4\u5458\u4f1a\uff08COFEPRIS\uff09\u5728\u5b98\u65b9\u516c\u62a5\uff08DOF\uff09\u4e0a\u53d1\u5e03\u4e86\u300a\u6d3b\u6027\u6210\u5206\u3001\u836f\u54c1\u548c\u533b\u7597\u5668\u68b0\u826f\u597d\u751f\u4ea7\u89c4\u8303\uff08GMP\uff09\u4fdd\u8bc1\u6587\u4ef6\u63d0\u4ea4\u6307\u5357\u534f\u8bae\u300b\u3002\u8be5\u6307\u5357\u9002\u7528\u4e8e\u65b0\u7684\u5065\u5eb7\u6ce8\u518c\u7533\u8bf7\uff0c\u4ee5\u53ca\u2026\u2026<\/p>","protected":false},"author":43,"featured_media":8207,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[521,35],"tags":[609],"class_list":["post-8174","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mexico-regulations","category-pharma-biotech-latest-insights","tag-guideline"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Mexico GMP 2025: Key Updates | RegASK<\/title>\n<meta name=\"description\" content=\"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, &amp; devices.Ensure seamless compliance now.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/zh\/\u58a8\u897f\u54e5gmp\u5408\u89c4\u60272025\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COFEPRIS (Mexico) Publishes Guidelines for GMP Documentation for Active Ingredients, Medicines, and Medical Devices Submissions\" \/>\n<meta property=\"og:description\" content=\"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, &amp; devices.Ensure seamless compliance now.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/zh\/\u58a8\u897f\u54e5gmp\u5408\u89c4\u60272025\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-03T19:30:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-09T06:29:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"COFEPRIS (Mexico) Publishes Guidelines for GMP Document&hellip;\",\"datePublished\":\"2025-04-03T19:30:11+00:00\",\"dateModified\":\"2025-04-09T06:29:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"keywords\":[\"Guideline\"],\"articleSection\":[\"Mexico\",\"Pharma and Biotech\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\",\"name\":\"Mexico GMP 2025: Key Updates | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"datePublished\":\"2025-04-03T19:30:11+00:00\",\"dateModified\":\"2025-04-09T06:29:54+00:00\",\"description\":\"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, & devices.Ensure seamless compliance now.\",\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/regask.com\\\/mexico-gmp-compliance-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png\",\"width\":800,\"height\":600,\"caption\":\"Cofepris Mexico Publishes Guidelines Gmp Documentation Active Ingredients Medicines Medical Devices Submissions\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u58a8\u897f\u54e5GMP 2025\uff1a\u91cd\u8981\u66f4\u65b0 | RegASK","description":"\u4fdd\u6301\u5408\u89c4\uff01COFEPRIS \u5c06\u4e8e 2025 \u5e74\u66f4\u65b0 GMP \u89c4\u5219\u3002API\u3001\u836f\u54c1\u548c\u8bbe\u5907\u65b9\u9762\u7684\u5173\u952e\u53d8\u5316\u3002\u7acb\u5373\u786e\u4fdd\u65e0\u7f1d\u5408\u89c4\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/zh\/\u58a8\u897f\u54e5gmp\u5408\u89c4\u60272025\/","og_locale":"zh_CN","og_type":"article","og_title":"COFEPRIS (Mexico) Publishes Guidelines for GMP Documentation for Active Ingredients, Medicines, and Medical Devices Submissions","og_description":"Stay compliant! COFEPRIS updates GMP rules in 2025. Key changes for APIs, drugs, & devices.Ensure seamless compliance now.","og_url":"https:\/\/regask.com\/zh\/\u58a8\u897f\u54e5gmp\u5408\u89c4\u60272025\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-04-03T19:30:11+00:00","article_modified_time":"2025-04-09T06:29:54+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u4f5c\u8005":"Reva Ananda","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#article","isPartOf":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"COFEPRIS (Mexico) Publishes Guidelines for GMP Document&hellip;","datePublished":"2025-04-03T19:30:11+00:00","dateModified":"2025-04-09T06:29:54+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/"},"wordCount":269,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","keywords":["Guideline"],"articleSection":["Mexico","Pharma and Biotech"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/","url":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/","name":"\u58a8\u897f\u54e5GMP 2025\uff1a\u91cd\u8981\u66f4\u65b0 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","datePublished":"2025-04-03T19:30:11+00:00","dateModified":"2025-04-09T06:29:54+00:00","description":"\u4fdd\u6301\u5408\u89c4\uff01COFEPRIS \u5c06\u4e8e 2025 \u5e74\u66f4\u65b0 GMP \u89c4\u5219\u3002API\u3001\u836f\u54c1\u548c\u8bbe\u5907\u65b9\u9762\u7684\u5173\u952e\u53d8\u5316\u3002\u7acb\u5373\u786e\u4fdd\u65e0\u7f1d\u5408\u89c4\u3002","inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/mexico-gmp-compliance-2025\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/regask.com\/mexico-gmp-compliance-2025\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/cofepris-mexico-publishes-guidelines-gmp-documentation-active-ingredients-medicines-medical-devices-submissions.png","width":800,"height":600,"caption":"Cofepris Mexico Publishes Guidelines Gmp Documentation Active Ingredients Medicines Medical Devices Submissions"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u9762\u5411\u9ad8\u6548\u56e2\u961f\u7684\u76d1\u7ba1\u4eba\u5de5\u667a\u80fd\u64cd\u4f5c\u7cfb\u7edf","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"\u745e\u74e6\u00b7\u963f\u5357\u8fbe"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/8174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/comments?post=8174"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/8174\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media\/8207"}],"wp:attachment":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media?parent=8174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/categories?post=8174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/tags?post=8174"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}